SJS Investment Consulting’s Day One Biopharmaceuticals DAWN Stock Holding History

SJS Investment Consulting’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39	Closed	-$837	–	2907
2026 Q1	$837	Buy	39 +19	+95%	+$268	﹤0.01%	1550
2025 Q4	$187	Buy	+20	New	+$167	﹤0.01%	1825

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SJS Investment Consulting's DAWN Position: Q2 2026 in Review

SJS Investment Consulting sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 39 shares — an estimated $837 sold.

SJS Investment Consulting first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $837 in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

SJS Investment Consulting reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
SJS Investment Consulting sold 39 Day One Biopharmaceuticals shares in Q2 2026, an estimated $837.
SJS Investment Consulting first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
SJS Investment Consulting's Day One Biopharmaceuticals position peaked at $837 in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.